Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis1

Experimental autoimmune encephalomyelitis (EAE) is a CD4 Th1-mediated inflammatory demyelinating disorder of the CNS and a well-established animal model for multiple sclerosis. Src homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1) is a cytosolic tyrosine phosphatase that is involved in regulating the T cell activation cascade from signals initiated through the TCR. To study the role of SHP-1 in EAE pathogenesis, we immunized B10.PL mice heterozygous for deletion of the SHP-1 gene (mev+/−) and B10.PL wild-type mice with the immunodominant epitope of myelin basic protein (MBP Ac1-11). T cell proliferation and IFN-γ production were significantly increased in mev+/− mice after immunization with MBP Ac1-11. The frequency of MBP Ac1-11-specific CD4 T cells, analyzed by staining with fluorescently labeled tetramers (MBP1-11[4Y]: I-Au complexes), was increased in the draining lymph node cells of mev+/− mice compared with wild-type mice. In addition, mev+/− mice developed a more severe course of EAE with epitope spreading to proteolipid protein peptide 43-64. Finally, expansion of MBP Ac1-11-specific T cells in response to Ag was enhanced in mev+/− T cells, particularly at lower Ag concentrations. These data demonstrate that the level of SHP-1 plays an important role in regulating the activation threshold of autoreactive T cells.

[1]  E. Ward,et al.  Negative Selection during the Peripheral Immune Response to Antigen , 2001, The Journal of experimental medicine.

[2]  E. Ward,et al.  Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. , 2000, International immunology.

[3]  J. Bluestone,et al.  CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[4]  J. Bluestone,et al.  CD28 Costimulatory Blockade Exacerbates Disease Severity and Accelerates Epitope Spreading in a Virus-Induced Autoimmune Disease , 2000, Journal of Virology.

[5]  K. Siminovitch,et al.  Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. , 2000, Seminars in immunology.

[6]  F. Beermann,et al.  Impaired Natural Killing of MHC Class I-Deficient Targets by NK Cells Expressing a Catalytically Inactive Form of SHP-11 , 2000, The Journal of Immunology.

[7]  U. Lorenz,et al.  The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. , 1999, International immunology.

[8]  Yiling Lu,et al.  SHP-1 Regulates Lck-induced Phosphatidylinositol 3-Kinase Phosphorylation and Activity* , 1999, The Journal of Biological Chemistry.

[9]  K. Siminovitch,et al.  Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. , 1999, Journal of immunology.

[10]  H. Broxmeyer,et al.  Abnormal Chemokine-Induced Responses of Immature and Mature Hematopoietic Cells from Motheaten Mice Implicate the Protein Tyrosine Phosphatase Shp-1 in Chemokine Responses , 1999, The Journal of experimental medicine.

[11]  G. Mills,et al.  The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells. , 1999, Journal of immunology.

[12]  P. Allen,et al.  Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection. , 1999, Journal of immunology.

[13]  L. Borysiewicz,et al.  TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. , 1999, Journal of immunology.

[14]  Bryan R. G. Williams,et al.  Protein-tyrosine Phosphatase Shp-1 Is a Negative Regulator of IL-4- and IL-13-dependent Signal Transduction* , 1998, Journal of Biological Chemistry.

[15]  J. Bluestone,et al.  The functional significance of epitope spreading and its regulation by co‐stimulatory molecules , 1998, Immunological reviews.

[16]  D. Wylie,et al.  DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance. , 1997, Journal of immunology.

[17]  D. Greiner,et al.  Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. , 1997, Trends in biotechnology.

[18]  K. Tomita,et al.  Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase , 1997, International journal of experimental pathology.

[19]  T. Yi,et al.  Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. , 1997, Experimental hematology.

[20]  L. Shultz,et al.  Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. , 1997, Experimental hematology.

[21]  K. Ravichandran,et al.  Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Siminovitch,et al.  Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.

[23]  Lars Fugger,et al.  Quantitative Analysis of Peptides from Myelin Basic Protein Binding to the MHC Class II Protein, I-Au, Which Confers Susceptibility to Experimental Allergic Encephalomyelitis , 1996, Molecular medicine.

[24]  S. Miller,et al.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis , 1995, The Journal of experimental medicine.

[25]  J. Goverman,et al.  T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.

[26]  T. Pawson,et al.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.

[27]  A. Tobin,et al.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes , 1993, Nature.

[28]  R. Tisch,et al.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.

[29]  E. Sercarz,et al.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire. , 1993, Immunology today.

[30]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[31]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[32]  J. D. Marshall,et al.  Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Shultz,et al.  Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). , 1989, Experimental hematology.

[34]  J. Rothbard,et al.  Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells , 1988, The Journal of experimental medicine.

[35]  D. Greiner,et al.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer , 1987, The Journal of experimental medicine.

[36]  D. Greiner,et al.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro. , 1987, Journal of immunology.

[37]  R. Hardy,et al.  Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. , 1986, Science.

[38]  E. Alvord,et al.  Experimental allergic encephalomyelitis : a useful model for multiple sclerosis : a satellite conference of the International Society of Neurochemists held at the University of Washington, Seattle, Washington, July 16-19 1983 , 1984 .

[39]  L. Shultz,et al.  "Viable motheaten," a new allele at the motheaten locus. I. Pathology. , 1984, The American journal of pathology.

[40]  E. Unanue,et al.  The mouse mutant "motheaten." II. Functional studies of the immune system. , 1978, Journal of immunology.

[41]  E. Unanue,et al.  The mouse mutant "motheaten". I. Development of lymphocyte populations. , 1978, Journal of immunology.

[42]  E. Unanue,et al.  The Mouse Mutant “Motheaten” , 1978, The Journal of Immunology.

[43]  L. Shultz,et al.  Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. , 1976, Journal of immunology.

[44]  L. Shultz,et al.  Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. , 1975, The Journal of heredity.

[45]  D. McFarlin,et al.  Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.

[46]  L. Shultz,et al.  Genetically determined murine models of immunodeficiency. , 1987, Annual review of immunology.

[47]  Dubinin Np.  Genetics and pathology , 1974 .

[48]  R. Martenson,et al.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.